Diamant Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$401M Buy
401,310
+382,470
+2,030% +$18.1M 0.29% 58
2025
Q4
$959K Sell
18,840
-3,295
-15% -$168K 0.69% 29
2025
Q3
$1.23M Sell
22,135
-1,705
-7% -$99.8K 0.9% 24
2025
Q2
$1.65M Sell
23,840
-650
-3% -$44.2K 1.25% 21
2025
Q1
$1.7M Buy
24,490
+790
+3% +$65.2K 1.29% 18
2024
Q4
$2.04M Buy
23,700
+7,835
+49% +$847K 1.3% 18
2024
Q3
$1.89M Hold
15,865
1.18% 21
2024
Q2
$2.26M Buy
15,865
+665
+4% +$88.1K 1.52% 17
2024
Q1
$1.95M Buy
15,200
+200
+1% +$23.8K 1.35% 17
2023
Q4
$1.55M Buy
+15,000
New +$1.48M 1.15% 19

Other funds holding NVO

Diamant Asset Management's NVO Position: Q1 2026 in Review

Diamant Asset Management increased its Novo Nordisk (NVO) stake by 2,030% in Q1 2026, buying an estimated $18.1M and bringing the position to 401,310 shares worth $401M. The position accounts for 0.29% of the portfolio, ranked #58.

Diamant Asset Management first reported a position in NVO in Q4 2023 and has held it in 10 quarters since. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Diamant Asset Management held 401,310 shares of Novo Nordisk worth $401M as of Q1 2026.
  • Diamant Asset Management bought 382,470 Novo Nordisk shares in Q1 2026, an estimated $18.1M.
  • Novo Nordisk made up 0.29% of Diamant Asset Management's portfolio in Q1 2026, its #58 holding.
  • Diamant Asset Management first reported a position in Novo Nordisk in Q4 2023 and has held it in 10 quarters since.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Diamant Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.